Innoveren Scientific Inc.

Equities

IVRN

US4041243076

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 17:21:24 13/05/2024 BST			5-day change	1st Jan Change
0.0055 ^USD	-72.50%		0.00%	-95.26%

03-06	Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	CI
2023	Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

H-Cyte, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020

March 25, 2021 at 09:23 pm

H-CYTE, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was USD 2.150 million compared to USD 8.346 million a year ago. Operating loss was USD 7.092 million compared to USD 30.558 million a year ago. Net loss was USD 6.459 million compared to USD 29.807 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.34 a year ago.

Latest news about Innoveren Scientific Inc.

Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	03-06	CI
Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-15	CI
Innoveren Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11-15	CI
H-Cyte, Inc. has Changed its Name to Innoveren Scientific Inc	10/07/23	CI
Innoveren Scientific Inc. has Changed its Ticker to IVRN from HCYT	10/07/23	CI
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	22/05/23	CI
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	10/05/23	CI
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	09/05/23	CI
H-CYTE, Inc. announced that it expects to receive $0.135 million in funding	11/04/23	CI
H-CYTE, Inc. announced that it expects to receive $0.3 million in funding	23/02/23	CI
H-CYTE, Inc. (OTCQB: HCYT) completed the acquisition of SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown.	28/12/22	CI
H-CYTE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
H-CYTE, Inc. announced that it has received $0.225 million in funding	28/09/22	CI
H-CYTE, Inc. (OTCQB: HCYT) entered into a letter of intent to acquire SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown for $2.3 million.	18/09/22	CI
H-CYTE, Inc. cancelled the acquisition of Catheter Precision, Inc.	07/09/22	CI
H-CYTE, Inc. acquired Jantibody, LLC.	07/09/22	CI
H-CYTE, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22	CI
H-Cyte, Inc. Closes Its Clinic in Scottsdale, Arizona	09/06/22	CI
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	04/05/22	CI
H-CYTE, Inc. Moves its Headquarters	04/04/22	CI
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	25/02/22	CI
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	24/02/22	CI
H-CYTE, Inc. Appoints Richard Rosenblum and Matthew Anderer as Directors	14/01/22	CI
H-CYTE, Inc. entered into a letter of intent to acquire Catheter Precision, Inc.	10/01/22	CI
H-CYTE, Inc. Announces Resignation of Tanya Rhodes as Interim Chief Executive Officer	07/12/21	CI

Chart Innoveren Scientific Inc.

Duration

Period

More charts

Company Profile

Innoveren Scientific Inc. is a life science and biotech incubator company. The Company is focused on advancing new technologies in areas of unmet need across multiple indications for improving patient lives. The Company is also focused on investing in and fosters technologies that are supported by a scientific foundation.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INNOVEREN SCIENTIFIC INC.	-95.26%	29.36K
THERMO FISHER SCIENTIFIC	+7.87%	223B
DANAHER CORPORATION	+11.83%	195B
INTUITIVE SURGICAL, INC.	+18.87%	144B
BOSTON SCIENTIFIC CORPORATION	+30.03%	111B
SIEMENS HEALTHINEERS AG	+2.32%	65.19B
EDWARDS LIFESCIENCES CORPORATION	+14.15%	53.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2.68%	50.28B
AGILENT TECHNOLOGIES, INC.	+6.60%	44.15B
GE HEALTHCARE TECHNOLOGIES INC.	+1.85%	36.45B

Other Advanced Medical Equipment & Technology